AI in Healthcare: AITRICS‘ Breakthrough in Hong Kong
AI in healthcare revolutionizes patient care. AITRICS, a Korean AI enterprise, made significant advances by obtaining a medical device permit in Hong Kong for their solution, AITRICS-VC (VitalCare). This solution predicts patient emergencies using real-time data analysis from Electronic Medical Records (EMR).
Understanding AITRICS-VC Capabilities
Real-time EMR Analysis
AITRICS-VC focuses on monitoring patient data to predict severe health events in hospitals.
- General ward predictions:
- Acute serious events risk within 6 hours (death, cardiac arrest, ICU transfer)
- Sepsis risk within 4 hours
- Cardiac arrest risk within 24 hours
- ICU predictions:
- Death risk within 6 hours
Hong Kong’s Medical Landscape
Healthcare costs in Hong Kong during 2022-2023 amounted to 284 billion Hong Kong dollars, 10% of GDP. With ageing population and bed shortages, digital healthcare solutions like AITRICS-VC are increasingly in demand.
Benefits of AITRICS-VC
The system aids medical professionals in swift decision-making, enhancing patient safety and hospital efficiency.
- Supports rapid clinical judgment
- Improves patient safety
- Boosts hospital operational efficiency
Future Plans for AITRICS
AITRICS aims to be at the forefront of medical innovation in Hong Kong and expand across Asia. The CEO, Kim Kwang-jun, emphasizes leveraging clinical experiences to adapt to diverse regulatory environments in countries like the US and Vietnam.
Expansion Strategy
AITRICS plans to:
- Use its Hong Kong approval as a launchpad for wider Asian market penetration
- Develop products that provide tangible benefits in overseas medical environments
Previous Achievements and Collaborations
AITRICS’ track record includes several key milestones and collaborations:
- Gained “Innovative Medical Device Software Manufacturer” certification
- Expanded AI prediction use in partnership with Philips
- Entered non-insurance markets with their emergency prediction technology
Conclusion
AITRICS exemplifies the potential of AI in transforming healthcare through predictive solutions. Their recent accomplishment in Hong Kong marks a significant step forward, opening doors to broader Asian markets and international collaborations. Keeping an eye on their progress might be worthwhile as they continue to innovate and expand their reach in the healthcare industry.



![[South Korea] HUONS Meditech’s URO-UEMXD Expands Global Influence](https://i0.wp.com/productadvisor.com/wp-content/uploads/2024/10/huons-1.png?fit=800%2C616&ssl=1)